Cargando…

Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy

OBJECTIVE: This study aims to explore the expression pattern and prognostic significance of miR-33a in non-small cell lung cancer (NSCLC) treated with adjuvant chemotherapy. METHODS: MiR-33aexpression in NSCLC was analyzed in silico using the GEO database and was subsequently confirmed by quantitati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Li-Kun, Ma, Yu-Shui, Han, Yang, Lu, Gai-Xia, Luo, Pei, Chang, Zheng-Yan, Xie, Ru-Ting, Yang, Hui-Qiong, Chai, Li, Cai, Ming-Xiang, Wu, Ting-Miao, Yu, Fei, Qin, Shan-Shan, Lv, Zhong-Wei, Wu, Chun-Yan, Fu, Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283662/ https://www.ncbi.nlm.nih.gov/pubmed/28141816 http://dx.doi.org/10.1371/journal.pone.0170431

Ejemplares similares

High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1
por: Ma, Yu-Shui, et al.
Publicado: (2017)

A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype
por: Wang, Hao-Yuan, et al.
Publicado: (2016)

A signature of 33 immune‐related gene pairs predicts clinical outcome in hepatocellular carcinoma
por: Sun, Xiao‐Yan, et al.
Publicado: (2020)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

Prognostic implications of decreased microRNA-101-3p expression in patients with non-small cell lung cancer
por: Lu, Hai-Min, et al.
Publicado: (2018)

Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer
por: Tang, Xiaohuan, et al.
Publicado: (2022)

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients
por: Yu, Shan, et al.
Publicado: (2020)

Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma
por: LIU, SHAN-SHAN, et al.
Publicado: (2014)

MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis
por: Yan, Wei, et al.
Publicado: (2014)

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Ze-Kun, et al.
Publicado: (2022)

Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis
por: Zhang, Li, et al.
Publicado: (2022)

Identifying four DNA methylation gene sites signature for predicting prognosis of osteosarcoma
por: Zhang, Xijun, et al.
Publicado: (2020)

Role of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma
por: YANG, YAN, et al.
Publicado: (2016)

MicroRNA-33b Suppresses Migration and Invasion by Targeting c-Myc in Osteosarcoma Cells
por: Xu, Ning, et al.
Publicado: (2014)

A Five-MicroRNA Signature Predicts the Prognosis in Nasopharyngeal Carcinoma
por: Wu, Shixiong, et al.
Publicado: (2021)

Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients
por: Chen, Shan, et al.
Publicado: (2021)

A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients
por: Lu, Jia-huan, et al.
Publicado: (2018)

Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis
por: Yi, Shuhua, et al.
Publicado: (2020)

Phagocytosis-Regulators-Based Signature to Predict the Prognosis and Chemotherapy Resistance for Breast Cancer Patients
por: Feng, Juan, et al.
Publicado: (2022)

The four-microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients
por: Zhang, Siwei, et al.
Publicado: (2019)

The HSP70 gene predicts prognosis and response to chemotherapy in epithelial ovarian cancer
por: Li, Xiao-Fei, et al.
Publicado: (2021)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung Adenocarcinoma
por: Yang, Fan, et al.
Publicado: (2022)

Bone Marrow MicroRNA-335 Level Predicts the Chemotherapy Response and Prognosis of Adult Acute Myeloid Leukemia
por: Yingchun, Li, et al.
Publicado: (2015)

An epithelial–mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

MicroRNA-547-5p-mediated interleukin-33/suppressor of tumorigenicity 2 signaling underlies the genesis and maintenance of neuropathic pain and is targeted by the therapy with bone marrow stromal cells
por: Zhou, Ju, et al.
Publicado: (2020)

Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
por: Xing, Ai-Yan, et al.
Publicado: (2021)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

Development of an Aging-Related Gene Signature for Predicting Prognosis, Immunotherapy, and Chemotherapy Benefits in Rectal Cancer
por: Wang, Yangyang, et al.
Publicado: (2022)

A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy
por: Pan, Runsang, et al.
Publicado: (2022)

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
por: Wu, Jin, et al.
Publicado: (2022)

A novel immune-related microRNA signature for prognosis of thymoma
por: Wang, Bin, et al.
Publicado: (2022)

Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer
por: Dai, Yin-wei, et al.
Publicado: (2022)

Nursing Outcomes and Risk Factors of Patients with Chronic Obstructive Pulmonary Disease After Discharge
por: Chai, Yun-Hua, et al.
Publicado: (2021)

Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity
por: Jiang, Shan, et al.
Publicado: (2023)

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer
por: Zhou, Mingxuan, et al.
Publicado: (2022)

Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature
por: Yang, Yu, et al.
Publicado: (2021)

Prognostic Value of microRNA Signature in Patients with Gastric Cancers
por: Liu, Hai-Ting, et al.
Publicado: (2017)

MicroRNA-195 prevents hippocampal microglial/macrophage polarization towards the M1 phenotype induced by chronic brain hypoperfusion through regulating CX3CL1/CX3CR1 signaling
por: Mao, Meng, et al.
Publicado: (2020)

A MicroRNA Expression Signature In Taxane-anthracycline-based Neoadjuvant Chemotherapy Response
por: Zheng, Yi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_usro6fk2afs4uo3kbge2auacqn